Picture1.jpg
Clearmind Medicine Files Provisional Patent Application Related to Methods of Drug-Assisted Psychotherapy
13 oct. 2021 08h00 HE | Clearmind Medicine
TORONTO, Ontario, Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
ibn-iw-globe-2.png
InvestorBrandNetwork (IBN) and PsychedelicNewsWire (PNW) Announce Collaboration with Microdose Psychedelic Insights for the upcoming June Conferences
11 juin 2021 13h46 HE | InvestorBrandNetwork (IBN)
NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- via PsychedelicNewsWire -- InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, today announces that it will be...
MagicMed Industries to Present at the Q1 Virtual Investor Summit
19 mars 2021 08h15 HE | MagicMed Industries Inc.
CALGARY, Alberta, March 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- MagicMed Industries Inc. ("MagicMed" or the "Company"), a biotechnology company focused on creating novel psychedelic...
ibn-logo-color-2 (002).jpg
InvestorBrandNetwork Introduces PsychedelicNewsWire – A Technology Driven Communications Platform Focused on Emerging Market Opportunities in all Aspects of Psychedelics and Therapeutics
25 juin 2020 08h17 HE | InvestorBrandNetwork (IBN)
SAN FRANCISCO, June 25, 2020 (GLOBE NEWSWIRE) -- (June 25, 2020) – via NetworkWire – InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies...
MDMA Leader Mark Leahey to Speak at SEMDA 2013 Conference
20 déc. 2012 08h25 HE | Southeastern Medical Device Association
ATLANTA, GA--(Marketwire - Dec 20, 2012) - Mark B. Leahey, President and CEO for the Medical Device Manufacturers Association (MDMA), will speak at the SEMDA 2013 Conference. MDMA is a national...